Jane Street’s Connect Biopharma Holdings CNTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$104K Sell
39,598
-42,628
-52% -$111K ﹤0.01% 10637
2025
Q4
$232K Buy
+82,226
New +$175K ﹤0.01% 9416

Other funds holding CNTB

Jane Street's CNTB Position: Q1 2026 in Review

Jane Street reduced its Connect Biopharma Holdings (CNTB) stake by 52% in Q1 2026, selling an estimated $111K and leaving 39,598 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #10637.

Jane Street first reported a position in CNTB in Q4 2025 and has held it in 2 quarters since. The position peaked at $232K in Q4 2025. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Jane Street held 39,598 shares of Connect Biopharma Holdings worth $104K as of Q1 2026.
  • Jane Street sold 42,628 Connect Biopharma Holdings shares in Q1 2026, an estimated $111K.
  • Connect Biopharma Holdings made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10637 holding.
  • Jane Street first reported a position in Connect Biopharma Holdings in Q4 2025 and has held it in 2 quarters since.
  • Jane Street's Connect Biopharma Holdings position peaked at $232K in Q4 2025.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.